SUBSCRIBERS

Long-term view allows Temasek to be patient with poor performers

Published Tue, Jul 9, 2019 · 09:50 PM

Singapore

TEMASEK Holdings can stay the course with its poor performers because it invests for the long term.

The point was made at Temasek's annual review on Tuesday, after shares of German life science giant Bayer had fallen by 39 per cent since April 2018, when Temasek put an additional three billion euros (S$4.8 billion) into the company.

KEYWORDS IN THIS ARTICLE

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Companies & Markets

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here